IonQ, Inc.·4

Oct 4, 8:38 PM ET

Monroe Christopher 4

4 · IonQ, Inc. · Filed Oct 4, 2021

Insider Transaction Report

Form 4
Period: 2021-09-30
Monroe Christopher
Chief Scientist
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-09-30+246,684246,684 total
    Exercise: $0.16Exp: 2029-01-24Common Stock (246,684 underlying)
  • Award

    Employee Stock Option (right to buy)

    2021-09-30+1,214,5351,214,535 total
    Exercise: $0.69Exp: 2030-11-02Common Stock (1,214,535 underlying)
  • Award

    Employee Stock Option (right to buy)

    2021-09-30+404,845404,845 total
    Exercise: $2.40Exp: 2031-03-03Common Stock (404,845 underlying)
  • Award

    Common Stock

    2021-09-30+6,534,1386,534,138 total
Footnotes (4)
  • [F1]Received on September 30, 2021 pursuant to that certain Agreement and Plan of Merger ("Merger"), dated as of March 7, 2021, by and among dMY Technology Group, Inc. III, a Delaware corporation ("dMY"), Ion Trap Acquisition Inc., a Delaware corporation and a wholly-owned subsidiary of dMY, and IonQ, Inc., a Delaware corporation ("Former IonQ"), in exchange for Former IonQ shares.
  • [F2]The shares underlying the option vested or shall vest 1/60th on the last day of each month commencing on September 30, 2018, subject to the Reporting Person continuously providing service to the Issuer.
  • [F3]The shares underlying the option vested or shall vest 1/60th on the last day of each month commencing on December 31, 2020, subject to the Reporting Person continuously providing service to the Issuer.
  • [F4]The shares underlying the option vested or shall vest 1/60th on the last day of each month commencing on April 30, 2021, subject to the Reporting Person continuously providing service to the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION